GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
2

21st North ULGX · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 2 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2014

Revenue

$14.2m

FY2014FY2014

Net income

−$7.6m

FY2014FY2014

Free cash flow

−$1.6m

FY2014FY2014

Shareholders' equity

−$7.0m

FY2014FY2014

Income statement

Fiscal years

FY2014
Revenue$14.2m
Gross profit$6.1m
Research and development$1.6m
Operating income−$6.9m
Net income−$7.6m
Diluted earnings per share-0.35

Balance sheet

At each fiscal year end

FY2014
Total assets$5.7m
Cash and short-term investments$718,000
Total liabilities$12.6m
Debt$5.3m
Shareholders' equity−$7.0m
Shares outstanding22m

Cash flow

Fiscal years

FY2014
Cash from operations−$1.5m
Capital spending−$42,000
Free cash flow−$1.6m

Latest quarters

By quarter end

Mar 2015Dec 2014Sept 2014Jun 2014Mar 2014Dec 2013Sept 2013Jun 2013
Revenue$2.8m$3.1m$3.0m$3.3m$3.4m$3.8m$3.8m$4.2m
Gross profit$1.3m$1.5m$1.5m$1.6m$849,000$1.8m$1.9m$1.9m
Operating income−$153,000−$134,000−$241,000−$3.4m−$1.5m−$892,000−$1.2m−$1.3m
Net income−$349,000−$357,000−$437,000−$3.5m−$1.7m−$1.1m−$1.3m−$1.2m
Diluted earnings per share-0.02-0.02-0.02-0.16-0.08-0.05-0.06-0.06
Cash from operations———————−$1.0m
Total assets$5.0m$5.3m$5.5m$5.7m$9.3m$10.8m$11.9m$12.5m
Cash and short-term investments$492,000$530,000$545,000$718,000$816,000$1.3m$1.6m$2.3m
Debt$5.3m$5.3m$5.3m$5.3m$5.3m$5.3m$5.3m$5.3m
Shareholders' equity−$8.1m−$7.7m−$7.4m−$7.0m−$3.5m−$1.9m−$846,000$420,000

Growth per year

Compound annual rate

3 years5 years10 years
Revenue4.2%2.1%-5.2%
Operating income23.0%9.2%—
Net income26.8%11.5%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin46.3%48.3%49.8%54.9%
Operating margin-35.2%-31.0%-28.9%-23.3%
Net margin-38.6%-33.6%-30.6%-23.0%

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%0%100%100%836%143%7028%22649%18610%10652%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.